Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phosphate kinetics during different dialysis modalities.

Ranistha Ratanarat1, Alessandra Brendolan, Gopel Volker

  • 1Department of Nephrology, Dialysis and Transplantation, St Bortolo Hospital, Vicenza, Italy.

Blood Purification
|January 4, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hemoadsorption Combined with Hemodialysis (HAHD): a Consensus Statement from an International Expert Panel.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Assessment of Safety and Efficacy of Expanded Hemodialysis with Medium Cut-Off Dialyzer Compared to Haemodiafiltration.

Journal of clinical medicine·2025
Same author

The role of sex and gender in acute kidney injury-consensus statements from the 33rd Acute Disease Quality Initiative.

Kidney international·2025
Same author

Antibiotics Removal during Continuous Renal Replacement Therapy in Septic Shock Patients: Mixed Modality Versus "Expanded Haemodialysis".

Clinical pharmacokinetics·2024
Same author

Human Proenkephalin A 119-159 (penKid) in Extracorporeal Therapies: Ex vivo Sieving Coefficient, Diffusive Clearance, and Hemoadsorption Kinetics.

Blood purification·2024
Same author

Immunomodulation Driven by Theranova Filter during a Single HD Session.

Journal of clinical medicine·2024
Same journal

Peritoneal Glucose Uptake Reduction by Sodium-Glucose Co-Transporter 2 Inhibitors in Clinical Peritoneal Dialysis.

Blood purification·2026
Same journal

With the Generalization of AI and Algorithms, Will We Still Need a Nephrologist in the Dialysis Room?

Blood purification·2026
Same journal

Could serum CA125 aid the clinical assessment of volume status of end-stage kidney disease patients treated by peritoneal dialysis patients?

Blood purification·2026
Same journal

From Bench to Bedside: Implications and Interventions for Endotoxin Exposure in Lipopolysaccharide-Induced Apoptosis and Eryptosis.

Blood purification·2026
Same journal

Feasibility Study of a Smartphone App and Web Portal for Remote Monitoring of Chronic Kidney Disease and Peritoneal Dialysis populations: A mixed-method study.

Blood purification·2026
Same journal

Treatment of Focal Segmental Glomerulosclerosis in Low- and Middle-Income Countries: Emerging Extracorporeal Therapies.

Blood purification·2026
See all related articles

Phosphate removal varies significantly across intermittent hemodialysis (IHD), slow low-efficiency dialysis (SLED), and continuous renal replacement therapy (CRRT). Treatment duration, not modality, is the key factor influencing total phosphate removal in acute renal failure patients.

Area of Science:

  • Nephrology
  • Intensive Care Medicine
  • Biochemistry

Background:

  • Abnormal serum phosphate is prevalent in acute renal failure (ARF) patients (65-80%).
  • Phosphate removal kinetics are established for intermittent hemodialysis (IHD) but not for slow low-efficiency dialysis (SLED) or continuous renal replacement therapy (CRRT).

Purpose of the Study:

  • To evaluate and compare phosphate removal and kinetics across IHD, SLED, and CRRT modalities.
  • To investigate the factors influencing intradialytic phosphate levels in critically ill patients with renal failure.

Main Methods:

  • Phosphate kinetics and removal were assessed in 8 IHD, 8 SLED, and 10 CRRT (continuous venovenous hemofiltration - CVVH) patients with low residual renal clearance.
  • Phosphate clearance (Kp) and solute removal were quantified using direct dialysate quantification (DDQ) with phosphate-free dialysis/replacement fluid.

Related Experiment Videos

Main Results:

  • Phosphate clearance (Kp) was highest with IHD (126.9 ml/min), followed by SLED (58.0 ml/min), and lowest with CVVH (31.5 ml/min).
  • Total phosphate removal was significantly higher in longer treatments, irrespective of modality (IHD: 29.9 mmol, SLED: 37.6 mmol, CVVH: 66.7 mmol).
  • Treatment duration was the sole significant determinant of phosphate removal (r=0.7, p<0.0001); phosphate rebound extended beyond 1 hour post-dialysis, particularly in shorter treatments.

Conclusions:

  • This study provides crucial data on phosphate removal and intradialytic kinetics across different dialysis modalities in renal failure.
  • Findings will aid clinicians in optimizing phosphate management, including supplementation and treatment intensity planning.